Article

A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: A propensity-matched study

University of Alabama at Birmingham, 1530 3rd Avenue South, CH-19, Ste-219, Birmingham, AL 35294-2041, USA.
European Heart Journal (Impact Factor: 15.2). 07/2009; 30(16):2029-37. DOI: 10.1093/eurheartj/ehp222
Source: PubMed

ABSTRACT

Atrial fibrillation (AF)-associated poor outcomes in heart failure (HF) are often attributed to older age, advanced disease, and comorbidity burden of HF patients with AF. Therefore, we examined the effect of AF on outcomes in a propensity-matched study in which patients with and without AF were well balanced on all measured baseline characteristics.
Of the 2708 advanced chronic systolic HF patients in the Beta-Blocker Evaluation of Survival Trial, 653 had a history of AF. Propensity scores for AF were calculated for each patient and were used to assemble a cohort of 487 pairs of patients with and without AF who were balanced on 74 baseline characteristics. Matched Cox regression analyses were used to estimate associations of AF with outcomes during 23 months of mean follow-up. All-cause mortality occurred in 187 (rate, 2046/10,000 person-years of follow-up) and 181 (rate, 1885/10,000 person-years) matched patients with and without AF, respectively [matched hazard ratio (HR) when AF was compared with no-AF 1.03, 95% confidence interval (CI) 0.79-1.33; P = 0.84]. Heart failure hospitalization occurred in 215 (rate, 3171/10,000 person-years) and 184 (rate, 2405/10,000 person-years) matched patients with and without AF, respectively (matched HR when AF was compared with no-AF 1.28, 95% CI 1.00-1.63; P = 0.049). Hazard ratios and 95% CIs for AF-associated HF hospitalization for bucindolol and placebo groups were, respectively, 1.08 (0.81-1.43) and 1.54 (1.17-2.03; P for interaction = 0.09).
A history of AF had no intrinsic association with mortality but was associated with HF hospitalization in chronic systolic HF.

Download full-text

Full-text

Available from: Michel White, Mar 28, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Riassunto. La fibrillazione atriale (FA) e lo scompenso car-diaco (SC) sono due condizioni ampiamente diffuse nella popolazione, soprattutto di età avanzata. Quando coesi-stono nello stesso paziente, come frequentemente accade, innescano lo sviluppo di un circolo vizioso di reciproco con-dizionamento che, drammaticamente, esita nel ridurre la qualità della vita e nell'aumentare il tasso di mortalità. La re-lazione tra FA e SC è da tempo nota ed ampiamente stu-diata: si tratta di un campo del sapere in continuo divenire poiché, accanto alle provate conoscenze, in particolare fi-siopatogenetiche, si aprono nuovi orizzonti di ricerca, in quanto molti aspetti sono ancora oscuri. Questo limite, in-fatti, si riflette nella complessità del trattamento combina-to della FA e SC nella pratica clinica. Spiega, inoltre, il persi-stere di una prognosi spesso infausta, nonostante i pro-gressi terapeutici. In questa rassegna si ripercorrono le prin-cipali conoscenze sulla fisiopatologia che correla SC e FA; si forniscono alcuni dati epidemiologici, clinici e terapeutici, si sottolineano le nuove aree di ricerca, le acquisizioni più re-centi, ed, infine, i quesiti ancora irrisolti. Parole chiave. Cardiomiopatia indotta da tachicardia, fi-brillazione atriale, scompenso cardiaco. Summary. Atrial fibrillation and heart failure. Atrial fibrillation (AF) and heart failure (HF) are two condi-tions widespread on the population, especially in elderly people. When AF and HF coexist in the same patient, as fre-quently happens, they trigger a vicious circle of mutual in-fluence, who dramatically hesitates in lower quality of life and in increased mortality. The relationship between AF and HF is long and vigorously investigated: it is an ever-changing field of knowledge because alongside well known and proven results, especially the pathophysiological ones, there are new horizons of research since many aspects are still obscure. Hence, this limit is reflected in the complexity of the combined management of AF and HF in clinical prac-tice. It also explains an ominous prognosis despite signifi-cant therapeutic advances. In this review we go over again the well-established knowledge about the pathophysiolo-gy binder HF and AF; we provide some epidemiological, clinical and therapeutic informations, we also highlight the new acquisitions, the new research areas and, finally, the still unresolved questions.
    Full-text · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hypertension is a risk factor for incident heart failure (HF). However, the effect of uncontrolled blood pressure (BP) on incident HF in older adults with hypertension has not been prospectively examined in propensity-matched studies. Of the 5795 Cardiovascular Health Study participants, > or =65 years, 2562 with self-reported physician-diagnosed hypertension had no baseline HF. Of these, 1391 had uncontrolled hypertension, defined as systolic BP (SBP) > or =140 (n = 1373) or diastolic BP > or =90 mm Hg (n = 18). Propensity scores for uncontrolled hypertension, calculated for each participant, were used to assemble a cohort of 1021 pairs of participants with controlled and uncontrolled hypertension who were balanced on 31 baseline characteristics. Centrally adjudicated incident HF developed in 23% and 26% of participants with controlled and uncontrolled hypertension respectively during 13 years of follow-up (matched hazard ratio [HR] when uncontrolled hypertension was compared with controlled hypertension, 1.39; 95% confidence interval [CI], 1.12 to 1.73; P = .003). HRs (95% CI) for incident HF for those with (n = 503) and without (n = 1539) chronic kidney disease (CKD) were 1.73 (95% CI, 1.26 to 2.38; P = .001) and 1.08 (95% CI, 0.87 to 1.34; P = .486) respectively (P for interaction, .012). Compared with participants with controlled hypertension, HRs for incident HF associated with SBP 140 to 159 and > or =160 mm Hg were 1.06 (95% CI, 0.86 to 1.31; P = .572) and 1.58 (95% CI, 1.27 to 1.96; P < .0001), respectively. In community-dwelling older adults with hypertension, those with uncontrolled (versus controlled) BP have increased risk of new-onset HF, which is more pronounced in those with SBP > or =160 mm Hg and with CKD.
    Full-text · Article · Feb 2010 · Journal of the American Society of Hypertension
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To determine the association between obesity and outcomes in post-acute myocardial infarction (AMI) patients with systolic heart failure (HF). Of the 6632 Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) participants, 6611 had data on baseline body mass index (BMI) and 6561 had BMI > or = 18.5 kg/m(2). Of these, 1573 were obese (BMI > or = 30 kg/m(2)) and 4988 were non-obese (BMI 18.5-29.9 kg/m(2)). Propensity scores for obesity, estimated for each patient, were used to assemble a cohort of 1519 pairs of obese and non-obese patients who were balanced on 65 baseline characteristics. All-cause mortality occurred in 13.7 and 13.8% of matched obese and non-obese patients, respectively, during 16 months of median follow-up [matched hazard ratio (HR) for obesity 0.98; 95% confidence interval (CI) 0.79-1.21; P = 0.831]. Before matching, the obese group was younger (mean age, 62 vs. 64 years; P < 0.0001) and had more women (37 vs. 26%; P < 0.0001). The paradoxical pre-match association between obesity and reduced mortality (unadjusted HR 0.82; 95% CI 0.70-0.95; P = 0.008) disappeared when adjusted for age alone (age-adjusted HR 0.91; 95% CI 0.78-1.06; P = 0.206) but not for gender alone (gender-adjusted HR 0.79; 95% CI 0.68-0.92; P = 0.003). Obesity had no association with mortality in 1573 pairs of age-matched obese and non-obese patients (age-adjusted HR 0.94; 95% CI 0.77-1.13; P = 0.484). In post-AMI patients with systolic HF, obesity provides no independent intrinsic survival benefit. The paradoxical unadjusted survival associated with obesity is largely explained by the younger age of obese patients.
    Full-text · Article · Mar 2010 · European Journal of Heart Failure
Show more